All lobbying filings

Ervin Graves Strategy Group, LLC

Ervin Graves Strategy Group, LLC filed a Q3 report for American Medicines Company on October 19, 2026, reporting $30,000 in lobbying income.

Lobbying for American Medicines Company · Manufacturer of Generic Medication

As filed: ERVIN GRAVES STRATEGY GROUP, LLC for AMERICAN MEDICINES COMPANY.

All filings by Ervin Graves Strategy Group, LLC · Everything American Medicines Company has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.